SFP™ combines the advantages of two established concepts of modern laser medicine: The high effectiveness of selective photothermolysis (SP) and the low-risk and low-side-effect application of fractional photothermolysis (FP).
The result is a fast and effective treatment, without unwanted side effects.
Everything you need to know about SFP™ at a glance:
Both doctors and patients need a fast and effective treatment method without side effects. SFP™ is therefore based on two key elements.
For the treatment of diffuse redness, SFP™ uses the yellow FlexSys® laser with a selective wavelength of 577 nm. This wavelength is perfect for vascular treatments as it is specifically absorbed by the red blood pigment (HBO₂).
The red vessel as the target structure is effectively removed, while the surrounding tissue remains undamaged. SFP™ therefore delivers fantastic results in an amazingly short time.
The risks of the classic SP approach are overcome with SFP™ by using the fractional FlexSys® scanner. This drastically reduces the risk of unwanted side effects without reducing the effectiveness of the treatment. SFP™ delivers full-surface results with only partial-surface treatment.
The fractional application also enables very safe treatment with high energy densities of up to 25 J/cm² – without any cooling.
SFP™ treatment with the FlexSys® delivers comprehensive treatment results in a short time and without undesirable side effects.
The durable, high-quality laser in combination with the state-of-the-art fractional scanner make the FlexSys® the ideal tool for this ground-breaking way of using a yellow laser for vascular treatments.
The yellow FlexSys® module with a wavelength of 577 nm is ideal for vascular indications such as rosacea.
With a power density of up to 1,300 W/cm², the FlexSys® guarantees fast and impressive results.
The FlexSys® fractional scanner offers very small spot sizes. This is ideal for fine vessels and minimises the risk of temporary treatment marks.
The adjustable coverage (30 – 50 % for rosacea) makes the treatment particularly safe, even when high energy densities are used.
For SFP™, the FlexSys® does not require cooling. In addition, no pressure needs to be applied to the vessels.
During treatment, vessels remain fully targetable for the laser, leading to fast and lasting results.
“Let’s put one and one together: SFP™ – Selective Fractional Photothermolysis. This is a new concept for the safe treatment of a wide range of important dermatological indications with excellent results.
Dieter Manstein, MD, PhD
Assistant Professor of Dermatology
Harvard Medical School
